Chandipura Virus Infection Claims 6 Children
Six children in Gujarat have succumbed to suspected Chandipura virus infection, prompting urgent public health measures and raising awareness about this deadly virus.
Read More
Novo Holdings Commits USD 100 Million Investment in Asceneuron
Novo Holdings has announced a $100 million investment in Swiss biotech firm Asceneuron, aimed at accelerating the development of innovative treatments for neurodegenerative diseases. This strategic funding highlights the potential impact of Asceneuron’s research on the biotech industry and patient care.
Rising Zika Virus Cases in Pune Sparks Alarming Concerns: Total Infections Reach 19
Pune is facing a growing health crisis as Zika virus cases climb to 19, with senior citizens and pregnant women among the most affected. Health officials are urging residents to take preventive measures.
Scientists Initiate Human Testing of Marburg Virus Vaccine
Oxford University scientists have started human testing of the Marburg virus vaccine, a crucial development in the fight against one of the world’s deadliest pathogens. The vaccine aims to protect healthcare workers and vulnerable populations in regions prone to outbreaks.
Tragic Surge: Over 800 Students Test HIV Positive in Tripura Due to Drug Abuse
In a shocking development, over 800 students have tested HIV positive in Tripura, primarily due to injectable drug use. This alarming situation highlights the urgent need for effective drug abuse prevention and HIV awareness programs to safeguard the youth in the region.
AI-Based Pharma IT Hub to Create 50,000 Jobs
Ameenpur is set for a major transformation with the launch of an AI-based pharma IT hub, creating 50,000 jobs. This initiative will revolutionize pharmaceutical technology, boost the local economy, and position Ameenpur as a global leader in pharma and IT integration.
Pulsus Group Commits Rs 300 Crore to Transformative AI-Driven Pharma Healthcare IT Hub in Telangana
Pulsus Group announces a Rs 300 crore investment in an AI-driven pharma healthcare IT hub in Telangana, aiming to revolutionize healthcare with cutting-edge technology and innovation.
Emcure Pharmaceuticals IPO: Key Insights, Pros, and Cons for Investors in 2024
The Emcure Pharmaceuticals IPO, opening from July 3 to July 5, 2024, aims to raise approximately Rs. 1,952.03 crore. Here are key factors to consider when deciding whether to subscribe: